|Title:||Status of antituberculosis drug resistance in Saudi Arabia 1979-98|
|Authors:||Abu Amero, K.K.|
|Abstract:||All published material on the prevalence of drug-resistant tuberculosis within Saudi Arabia over the period 1979-98 was reviewed. The prevalence of single-drug-resistant tuberculosis ranged from 3.4% to 41% for isoniazid, 0% to 23.4% for rifampicin, 0.7% to 22.7% for streptomycin and 0% to 6.9% for ethambutol. The prevalence of multidrug-resistant tuberculosis [defined by WHO as resist1qance to two or more first-line antituberculosis drugs] ranged from 1.5% to 44% in different regions. No strong conclusions could be drawn owing to variations in the populations studied, geographical origins, site of Mycobacterium tuberculosis isolation [pulmonary or extrapulmonary] and drug sensitivity testing. However, the need to develop a standardized national policy for surveillance of drug-resistant tuberculosis in Saudi Arabia is clear|
Drug Resistance, Multiple, Bacterial
Microbial Sensitivity Tests
|Appears in Collections:||EMRO Journal Articles (EMHJ)|
Items in WHO IRIS are protected by copyright, with all rights reserved, unless otherwise indicated.